• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinica

tetano

Editor, Senior Moderator
J Antimicrob Chemother. 2019 Oct 9. pii: dkz411. doi: 10.1093/jac/dkz411. [Epub ahead of print] [h=1]Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).[/h]
Rockenschaub P[SUP]1[/SUP], Jhass A[SUP]2[/SUP], Freemantle N[SUP]3[/SUP], Aryee A[SUP]1[/SUP], Rafiq M[SUP]1[/SUP], Hayward A[SUP]4[/SUP], Shallcross L[SUP]1[/SUP].
[h=3]Author information[/h] 1 Institute of Health Informatics, University College London, 222 Euston Rd, London, UK. 2 Primary Care & Population Health, University College London, Rowland Hill Street, London, UK. 3 Institute of Clinical Trials and Methodology, University College London, 90 High Holborn, London, UK. 4 Institute of Epidemiology & Healthcare, University College London, 1-19 Torrington Place, London, UK.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] In primary care there is uncertainty about which patients with acute exacerbations of COPD (AECOPD) benefit from antibiotics.
[h=4]OBJECTIVES:[/h] To identify which types of COPD patients get the most antibiotics in primary care to support targeted antibiotic stewardship.
[h=4]METHODS:[/h] Observational study of COPD patients using a large English primary care database with 12 month follow-up. We estimated the incidence of and risk factors for antibiotic prescribing relative to the number of AECOPD during follow-up, considering COPD severity, smoking, obesity and comorbidity.
[h=4]RESULTS:[/h] From 157 practices, 19594 patients were diagnosed with COPD, representing 2.6% of patients and 11.5% of all prescribed antibiotics. Eight hundred and thirty-three (4.5%) patients with severe COPD and frequent AECOPD were prescribed six to nine prescriptions per year and accounted for 13.0% of antibiotics. Individuals with mild to moderate COPD and zero or one AECOPD received one to three prescriptions per year but accounted for 42.5% of all prescriptions. In addition to COPD severity, asthma, chronic heart disease, diabetes, heart failure and influenza vaccination were independently associated with increased antibiotic use.
[h=4]CONCLUSIONS:[/h] Patients with severe COPD have the highest rates of antibiotic prescribing but most antibiotics are prescribed for patients with mild to moderate COPD. Antibiotic stewardship should focus on the dual goals of safely reducing the volume of prescribing in patients with mild to moderate COPD, and optimizing prescribing in patients with severe disease who are at significant risk of drug resistance.
? The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.


PMID: 31598669 DOI: 10.1093/jac/dkz411
 
Back
Top Bottom